Skip to main content
. 2014 Jul 31;5(16):6947–6963. doi: 10.18632/oncotarget.2285

Figure 4. Kaplan-Meier survival curves of node-negative, untreated ER+/HER2- patients stratified by using the CycHyp signature to detect.

Figure 4

(A.) false positive patients among those identified at high risk based on the NPI nomenclature and (B.) false negative patients among those identified at low risk based on the NPI nomenclature (DFS Mantel-Cox comparison).